{"schema_version":"secwatch.filing_event.v1","accession":"0000885725-25-000013","form_type":"8-K","ticker":"BSX","cik":"0000885725","company_name":"BOSTON SCIENTIFIC CORP","filed_at":"2025-02-26T23:59:59+00:00","discovered_at":"2026-05-14T18:03:06.681301+00:00","generated_at":"2026-05-26T04:12:46.275009+00:00","sec_items":["1.01","2.03","8.01","9.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Boston Scientific subsidiary prices €1.5B senior notes to refinance 2025 maturity","bullets":["AMS Europe issued €850M 3.000% notes due 2031 and €650M 3.250% notes due 2034.","Net proceeds of approximately €1.487B after underwriting discount and expenses.","Proceeds will fund repayment of AMS Europe's 0.750% notes due March 8, 2025.","Remaining proceeds for general corporate purposes including acquisitions.","Notes are fully and unconditionally guaranteed by Boston Scientific."],"urls":{"canonical":"https://secwatch.observer/filing/0000885725-25-000013","json":"https://secwatch.observer/filing/0000885725-25-000013.json","markdown":"https://secwatch.observer/filing/0000885725-25-000013.md","text":"https://secwatch.observer/filing/0000885725-25-000013.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/885725/000088572525000013/0000885725-25-000013-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/885725/000088572525000013/bsx-20250221.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-26T04:12:46.275009+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}